These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27613110)

  • 41. Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease.
    Noordzij MJ; Lefrandt JD; Loeffen EA; Saleem BR; Meerwaldt R; Lutgers HL; Smit AJ; Zeebregts CJ
    Int J Cardiovasc Imaging; 2012 Feb; 28(2):431-8. PubMed ID: 21336554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant.
    Calviño J; Cigarran S; Gonzalez-Tabares L; Menendez N; Latorre J; Cillero S; Millan B; Cobelo C; Sanjurjo-Amado A; Quispe J; Garcia-Enriquez A; Carrero JJ
    PLoS One; 2018; 13(8):e0201118. PubMed ID: 30067789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Skin autofluorescence corresponds to microvascular reactivity in diabetes mellitus.
    Škrha J; Horová E; Šoupal J; Valeriánová A; Malík J; Prázný M; Zima T; Kalousová M; Škrha J
    J Diabetes Complications; 2022 Jul; 36(7):108206. PubMed ID: 35644724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Skin autofluorescence reflects integration of past long-term glycemic control in patients with type 1 diabetes.
    Sugisawa E; Miura J; Iwamoto Y; Uchigata Y
    Diabetes Care; 2013 Aug; 36(8):2339-45. PubMed ID: 23579177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diabetic retinopathy in well-controlled type 2 diabetes: Role of glycaemic memory.
    Ducos C; Rigo M; Larroumet A; Delyfer MN; Korobelnik JF; Monlun M; Foussard N; Poupon P; Haissaguerre M; Blanco L; Mohammedi K; Rigalleau V
    Diabetes Metab; 2021 Feb; 47(1):101156. PubMed ID: 32387701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship of skin autofluorescence to severity of retinopathy in type 2 diabetes.
    Yasuda M; Shimura M; Kunikata H; Kanazawa H; Yasuda K; Tanaka Y; Konno H; Takahashi M; Kokubun T; Maruyama K; Sato N; Kakizaki M; Sato M; Tsuji I; Miyata T; Nakazawa T
    Curr Eye Res; 2015 Mar; 40(3):338-45. PubMed ID: 24871684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Associations between Skin Autofluorescence Levels with Cardiovascular Risk and Diabetes Complications in Patients with Type 2 Diabetes.
    Reurean-Pintilei D; Pantea Stoian A; Salmen T; Stoica RA; Mititelu-Tartau L; Lazăr S; Timar B
    Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular events after a dramatic reduction of HbA1c in hospitalized subjects with type 2 diabetes and high long-term glucose exposure.
    Rigalleau V; Larroumet A; Ducos C; Rigo M; Barbet-Massin MA; Majchrzak C; Mohammedi K; Baillet-Blanco L; Monlun M; Rami-Arab L; Foussard N
    J Diabetes Complications; 2022 Aug; 36(8):108234. PubMed ID: 35752528
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of Skin Autofluorescence Levels With Kidney Function Decline in Patients With Peripheral Artery Disease.
    Schutte E; de Vos LC; Lutgers HL; Lambers Heerspink HJ; Wolffenbuttel BH; Vart P; Zeebregts CJ; Gansevoort RT; Lefrandt JD
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1709-14. PubMed ID: 27365407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Skin Autofluorescence, as a Measure of AGE Accumulation in Individuals Suffering from Chronic Plaque Psoriasis.
    Kopeć-Pyciarz K; Makulska I; Zwolińska D; Łaczmański Ł; Baran W
    Mediators Inflamm; 2018; 2018():4016939. PubMed ID: 30363704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Measuring of Advanced Glycation End Products in Acute Stroke Care: Skin Autofluorescence as a Predictor of Ischemic Stroke Outcome in Patients with Diabetes Mellitus.
    Filipov A; Fuchshuber H; Kraus J; Ebert AD; Sandikci V; Alonso A
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329949
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Skin autofluorescence and malnutrition as predictors of mortality in persons receiving dialysis: a prospective cohort study.
    Viramontes Hörner D; Selby NM; Taal MW
    J Hum Nutr Diet; 2020 Dec; 33(6):852-861. PubMed ID: 32383489
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.
    Mukai H; Svedberg O; Lindholm B; Dai L; Heimbürger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
    Nephrol Dial Transplant; 2019 Mar; 34(3):442-448. PubMed ID: 29378035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between habitual dietary and lifestyle behaviours and skin autofluorescence (SAF), a marker of tissue accumulation of advanced glycation endproducts (AGEs), in healthy adults.
    Kellow NJ; Coughlan MT; Reid CM
    Eur J Nutr; 2018 Sep; 57(6):2209-2216. PubMed ID: 28656390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association Between Self-reported Physical Activity and Skin Autofluorescence, a Marker of Tissue Accumulation of Advanced Glycation End Products in Adults With Type 1 Diabetes: A Cross-sectional Study.
    Duda-Sobczak A; Falkowski B; Araszkiewicz A; Zozulinska-Ziolkiewicz D
    Clin Ther; 2018 Jun; 40(6):872-880. PubMed ID: 29567299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The association between dietary and skin advanced glycation end products: the Rotterdam Study.
    Chen J; Waqas K; Tan RC; Voortman T; Ikram MA; Nijsten TEC; de Groot LCPGM; Uitterlinden AG; Zillikens MC
    Am J Clin Nutr; 2020 Jul; 112(1):129-137. PubMed ID: 32453418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End-products, Is Associated With Sarcopenia.
    Waqas K; Chen J; Trajanoska K; Ikram MA; Uitterlinden AG; Rivadeneira F; Zillikens MC
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e793-e803. PubMed ID: 34453164
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes.
    Maran A; Morieri ML; Falaguasta D; Avogaro A; Fadini GP
    Diabetes Care; 2022 Oct; 45(10):2439-2444. PubMed ID: 35972256
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus.
    Kostolanská J; Jakus V; Barák L
    J Pediatr Endocrinol Metab; 2009 May; 22(5):433-42. PubMed ID: 19618662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cross-sectional evaluation of noninvasively detected skin intrinsic fluorescence and mean hemoglobin a1c in type 1 diabetes.
    Aroda VR; Conway BN; Fernandez SJ; Matter NI; Maynard JD; Orchard TJ; Ratner RE
    Diabetes Technol Ther; 2013 Feb; 15(2):117-23. PubMed ID: 23305087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.